sellWeak cluster of 210b5-1 plan
Carl Dambkowski sold $307k of APGE
Chief Medical Officer at Apogee Therapeutics, Inc.. 6,665 shares at an average of $46.07, traded Dec 4, 2024, filed Dec 6, 2024.
Warning score
17Value
$307k
6,665 shares
Holdings after
260,798
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +14Trade size$307k at market
- 0Share of holdings soldSold 2.5% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-126395, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 4, 2024 | SOpen-market sale Common Stock10b5-1 | -6,665 | $46.07 | $307k | 260,798 | Dec 6, 2024 |
Related signals
Other insiders at Apogee Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $103k 2,725 shares | -1% | |
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $103k 2,725 shares | -1% | |
| 0Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $455k 10,090 shares | -4% | |
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $101k 2,725 shares | -1% | |
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $97k 2,725 shares | -1% | |
| 6Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $140k 3,860 shares | -2% | |
| 27Weak | Apogee Therapeutics, Inc. | Michael Thomas Henderson Chief Executive Officer | $302k 10,000 shares | -1% | |
| 10Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $48k 1,590 shares | -1% | |
| 33Weak | Apogee Therapeutics, Inc. | Michael Thomas Henderson Chief Executive Officer | $609k 15,000 shares | -1% | |
| 0Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $143k 3,520 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.